KEGG   DRUG: Naltrexone and bupropion
Entry
D10751            Mixture   Drug                                   
Name
Naltrexone and bupropion;
Contrave (TN)
Product
CONTRAVE (Nalpropion Pharmaceuticals LLC)
Component
(Naltrexone hydrochloride [DR:D02095] | Naltrexone [DR:D05113] | Methylnaltrexone bromide [DR:D06618]), (Bupropion hydrochloride [DR:D00817] | Bupropion [DR:D07591] | Bupropion hydrobromide [DR:D07938])
Remark
ATC code: A08AA62
Product: D10751<US>
Efficacy
Antiobesity
Comment
Treatment of obesity
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
   A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
    A08AA Centrally acting antiobesity products
     A08AA62 Bupropion and naltrexone
      D10751  Naltrexone and bupropion <US>
USP drug classification [BR:br08302]
 Anti-Obesity Agents
  Bupropion Hydrochloride/ Naltrexone Hydrochloride
   D10751  Naltrexone and bupropion
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10751
Other DBs
PubChem: 273220347
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system